Renewed interest in Star Wars Battlefront 2 started to grow in early May, right around Star Wars Day (aka May the Fourth), ...

Hot off the conclusion of Andor ’s incredible Rebel Alliance origin story, fans have been clamoring for a great Star Wars game to play. The most unlikely candidate of all is now filling the void: Star ...

Objective To evaluate the efficacy and safety of an oral selective tyrosine kinase 2 (TYK2) inhibitor, deucravacitinib, in patients with active psoriatic arthritis (PsA). Methods In this double-blind, ...

Upgrade your clone troopers with the 41st Elite Corps Overhaul mod for Star Wars II (2017). Here's why this lore-friendly ...

Star Wars Episode IX The Rise of Skywalker Palpatine Theories. PALPATINE LIVES Theories!! DID Palpatine survive Return of the ...

Dave Filoni and Sam Witwer explain in detail the process of the Duel between Obi-Wan and Darth Maul during that episode. Let me know what you think in the comments down below! Like & Sub for more!!

Menu Talk: Pat and Bret share the latest food & beverage news, plus a conversation with Bret Lunsford, executive chef of Sally’s Apizza. By Patricia Cobe and Bret Thorn on Jun. 10, 2025 McDonald’s had ...

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

The Karnataka State Cabinet has approved the establishment of Quantum Research Park Phase 2 at the Indian Institute of Science, Bengaluru (IISc), as announced by Karnataka’s information technology (IT ...

Amongst Star Wars projects, “Andor” sets itself apart. Unlike the majority of Star Wars films and series, it makes do without any Jedi or Sith, and the force is almost never mentioned. “Andor” is a ...

Privately run businesses created just 37,000 new jobs in May — the smallest increase in more than two years — as the worst global trade wars since the 1930s spurred many firms to put a pause ...

A phase 2 study of Vigil Neuroscience’s iluzanebart has missed its biomarker and efficacy endpoints, prompting the Sanofi-bound biotech to stop a long-term extension trial of the TREM2 agonist ...